Physician profile
Randall W Smith
NPI 1649276627
$2,150.48
in general payments reported to CMS, 2019-2025
20 companies · $700 in 2025
The $700 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $88.48 · 2021: $207 · 2022: $373 · 2023: $359 · 2024: $221 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $464.33 | 2019-2025 | Contoura Vision, Clareon, Clareon Panoptix Pro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $453.86 | 2022-2025 | Xifaxan, Plenvu |
| Glaukos Corporation | $369.11 | 2023-2025 | Idosetr |
| Abbvie INC. | $144.40 | 2023-2025 | Alphagan P, Lumigan, Vuity |
| Tarsus Pharmaceuticals, INC. | $115.40 | 2025 | Xdemvy |
| Rxsight INC | $79.96 | 2021 | |
| Bausch & Lomb Americas INC. | $71.77 | 2022-2024 | Xiidra, Miebo, Vyzulta |
| Sun Pharmaceutical Industries INC. | $69.79 | 2024-2025 | |
| Carl Zeiss Meditec, INC. | $66.24 | 2019-2020 | |
| Johnson & Johnson Surgical Vision, INC. | $50.75 | 2019 | |
| Mallinckrodt Hospital Products INC. | $48.24 | 2022 | |
| Allergan, INC. | $46.76 | 2019-2021 | |
| Ocular Therapeutix, INC. | $39.04 | 2021 | |
| Lensar, INC. | $24.51 | 2025 | Lensar Laser System |
| Aerie Pharmaceuticals, INC. | $21.90 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.59 | 2020 | |
| Coherus Oncology, INC. | $18.44 | 2024 | |
| Harrow Eye, LLC | $16.34 | 2024 | Vevye |
| Omeros Corporation | $14.57 | 2019 | |
| Shire North American Group INC | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.